Autopsy report · NCT00987662

Irbesartan Versus Amlodipine: The OBI Study

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“no funding”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: Aristotle University Of Thessaloniki
Sponsor type: University, hospital or other
Conditions: Obesity; Hypertension
Interventions: Irbesartan; Amlodipine
Participants: 0
Sites: 1
Countries: Greece

Trials that died the same way

Prehabilitation in Patients on a Waiting List for a Transplant
“No funded” (91% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.